Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Tandem Meetings 2023 | Implementing pharmacogenomics-driven supportive care for stem cell transplant recipients

Justin Arnall • 21 Feb 2023
Tandem Meetings 2023
General

Justin Arnall, PharmD, BCOP, Atrium Health, Charlotte, NC, discusses the rationale and objectives of the IMPPACT study, which aims to implement a pharmacist-driven precision medicine service in patients undergoing stem cell transplantation (SCT). Dr Arnall explains that both the drugs and drug doses used to mitigate SCT-associated toxicities are not tailored to each patient. The IMPPACT study aims to identify specific genotypes that can help tailor supportive care following SCT. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Justin Arnall

4:25
The role of the pharmacist in interpreting & applying PGx results in transplant recipients
Justin Arnall • 21 Feb 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals